Can the absence of drug dispensing units in municipalities influence the abandonment of treatment by people living with HIV/AIDS?

Authors

DOI:

https://doi.org/10.30968/rbfhss.2023.143.0912

Abstract

Objective: to verify the existence of an association between abandonment to antiretroviral therapy (ART) by PLWHA and the lack of dispensing service in municipalities located in southern Brazil. Methods: an exploratory and analytical study was carried out based on records of People Living with HIV/AIDS (PLWHA) abandoning antiretroviral therapy (ART) in the South region of Brazil. We included the record of individuals who had not taken their medications for at least one hundred days. Data were collected through the Drugs Management System (SICLOM), Clinical Monitoring System of People Living with HIV/AIDS (SIMC) and Laboratory Test Control System (SISCEL), from october to november 2022, referring to records of users dated between 1986 and 2022. Results: the records of 21,861 users were checked. The mean abandonment rate was 814±831.7 days, ranging from 101 to 4,276 days. Most PLWHA on ART lived in Rio Grande do Sul (n=10,951; 50.1%), one of the states with the highest incidence of AIDS. Regarding the other socio-demographic characteristics, it was revealed that most were male (n=12,300; 56.4%), living in the countryside (n=15,905; 72.8%), with a mean age of 42.1±13.0, white (n=13,053; 59.7%) and with 4 to 7 years of schooling (n=6,192; 28.3%). The average time of ART use was 7.9±2.1 years, and 49.0% (n=10,718) of PLWHA before abandoning treatment had an undetectable viral load (<50 copies/mm3). In parallel to this, it was observed that the research participants who lived in cities that did not have Drug Dispensing Units (DDU) (p<0.02) had a 14.9% (CI 14.5 - 15.3) higher chance of abandoning their therapy when compared to those who lived in cities that had antiretroviral dispensing service. Conclusion: these findings pointed out that the abandonment of ART by PLWHA may be associated with the spatial distribution of DDUs. Therefore, decentralizing access to antiretroviral drugs is a strategy that can positively impact the quality of life and increase the survival time of patients in southern Brazil.

Downloads

Download data is not yet available.

References

Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Relatório de monitoramento clínico do HIV 2021. Brasília: Ministério da Saúde. 2022. 153 p. [internet]. Accessed jan 03, 2023. https:// bvsms.saude.gov.br/bvs/publicacoes/ relatorio_monitoramento_clinico_hiv_ 2021.pdf.

Miranda MMF, Oliveira DR, Quirino GS, et al. Adesão à terapia antirretroviral por adultos vivendo com HIV/AIDS: um estudo transversal. Rev Bras Enferm. 2022; 75(2): 1-9. doi:10.1590/0034-7167-2021-0019.

Reif LK, Abrams EJ, Arpadi S, et al. Interventions to Improve Antiretroviral Therapy Adherence Among Adolescents and Youth in Low- and Middle-Income Countries: A Systematic Review 2015-2019. AIDS Behav. 2020; 24(10): 2797-2810. doi: 10.1007/s10461-020-02822-4.

Carvalho PP, Barrroso SM, Coelho HC, et al. Fatores associados à adesão à terapia antirretroviral em adultos: revisão integrative de literatura. Cienc. saúde colet. 2019; 24(7): 2543-2555. doi: 10.1590/1413-8123201 8247.22312017.

Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe non-adherence to antiretroviral therapy. AIDS Care. 2016; 29(4): 418-422. doi: 10.1080/09540121.2016.1220478.

Bueno MAM, Simões TC, Luz TCB. Diferenças na disponibilidade de medicamentos prescritos na Atenção Primária: evidências do Projeto Prover. Ciênc. saúde coletiva. 2022; 27(03):1191-1203. doi: 10.1590/1413-81232022273.38782020.

Brasil. Instituto Brasileiro de Geografia e Estatística. Cidades. 2023. [internet]. Accessed dec 22, 2022. https://cidades.ibge.gov.br/.

Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Consulta uma UDM. 2022a. [internet]. Accessed nov 20, 2022. http://azt.aids.gov.br/.

Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis. Boletim epidemiológico HIV/AIDS 2021.Brasília: MS. 2021.72 p. [internet]. Accessed dec 02, 2022. https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/ epidemiologicos/especiais/2021/boletim-epidemiologico-especial-hiv-aids-2021.pdf/view.

Kerbauy G, Amaral VM, Nascimento JVS, et al. Pessoas vivendo com HIV em abandono do tratamento: resgate e promoção da saúde. Braz J Infect Dis. 2022; 26(2). doi: 10.1016/j.bjid.2022.102463.

Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/AIDS e das Hepatites Virais. Protocolo Clínico e Diretrizes Terapêuticas para Manejo da Infecção pelo HIV em Adultos. Brasília: Ministério da Saúde, 2018. 412 p.

Joint United Nations Programme on HIV/AIDS. Blind spot: reaching out to men and boys. 2017. [internet]. Accessed dec, 2022. http://www.unaids.org/sites/default/files/ media_asset/ blind_ spot_en.pdf.

Souza HC, Mota MR, Alves AR. Análise da adesão ao tratamento com antirretrovirais em pacientes com HIV/AIDS. Rev Bras Enferm. 2019; 72(5): 1295-1303. doi: 10.1590/0034-7167-2018-0115.

Benzaken AS, Oliveira MCP, Pereira GFM, et al. Presenting national HIV/ AIDS and sexually transmitted disease research in Brazil. Medicine. 2018; 97(1):S1-S2.14. doi: 10.1097/MD.0000000000010109.

Fontes MB, Crivelaro RC, Scartezini AM, et al. Determinant factors of knowledge, attitudes and practices regarding STD/AIDS and viral hepatitis among youths aged 18 to 29 years in Brazil. Ciênc. Saúde Coletiva. 2017; 22(4):1343-52. doi: 10.1590/1413-81232017224.12852015.

Miyada S, Garbin AJI, Colturato R, et al. Treatment adherence in patients living with HIV/AIDS assisted at a specialized facility in Brazil. Rev Soc Bras Med Trop. 2017; 50(5): 607-12. doi: 10.1590/0037-8682-0266-2017.

Melo GC, Carvalho ACA, Moreira AS, et al. Survival time and distance to access specialized treatment among people living with HIV/AIDS in the state of Alagoas, Brazil. Rev bras Epidemiol. 2021; 24 (suppl 1). doi:10.1590/1980549720210019.

Marins JR, Jamal LF, Chen SY, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17(11): 1675-82. doi: 10.1097/00002030-200307250-00012.

Zuber JFS, Muller EV, Borges PKO. Sobrevida de pessoas vivendo com HIV/AIDS na região dos Campos Gerais, Paraná 2008-2018. Research, Society and Development. 2021; 10(1). doi: 10.33448/rsd-v10i1.11444.

Amariles P, Galindo J, Mueses-Marin HF, et al . Efectividad y seguridad del esquema genérico lamivudina/tenofovir y efavirenz en pacientes con VIH/SIDA naïve: estudio fase IV no aleatorizado, Cali-Colombia 2012-2014. Rev. chil. Infectol. 2019; 36(1): 32-4.

Hamada Y, Getahun H, Tadesse BT, et al. HIV-associated tuberculosis. Int J STD AIDS. 2021; 32(9): 780-790. doi: 10.1177/0956462421992257.

Medeiros, LB. Fatores influentes no abandono do acompanhamento clínico ambulatorial por pessoas vivendo com HIV/Aids. Dissertação (Mestrado) – Programa de Pós-graduação em Modelos de Decisão e Saúde - Universidade Federal da Paraíba. 2016. 126 f.

Candido PGG, Amador BM, Silva FF, et al. Adherence to antiretroviral therapy among women living with HIV/AIDS in the interior of the Brazilian state of Pará: cross-sectional study. Sao Paulo Med J. 2021; 139(2): 99-106. doi: 10.1590/1516-3180.2020.0370.R1.18112020.

Folayan MO, Aliyu S, Oginni A, et al. Effectiveness of three delivery models for promoting access to pre-exposure prophylaxis in HIV-1 serodiscordant couples in Nigeria. PLoS One. 2022, 17(5): e0268011. doi: 10.1371/journal.pone.0268011.

Onwujekwe O, Chikezie I, Mbachu C, et al. Investigating client perception and attitude to decentralization of HIV/AIDS treatment services to primary health centres in three Nigerian states. Health Expect. 2016, (5): 1111-20. doi: 10.1111/hex.12403.

Brasil. Ministério da Saúde. Portaria Conjunta nº 1, de 16 de janeiro de 2013. Dispõe sobre a altera na tabela de Serviço Especializado no Sistema de Cadastro Nacional de Estabelecimentos de Saúde (SCNES), o Serviço 106 de Atenção a DST/HIV/AIDS, e institui o regulamento de serviços de atenção às DST/HIV/AIDS, que define suas modalidades, classificação, Organização das estruturas e o funcionamento. Diário Oficial da União. 17 de janeiro de 2013. Accessed jan 04, 2023. https://www.saude.sc.gov.br/index.php/informacoes-gerais-documentos/assistencia-farmaceutica/componente-estrategico/informes/10587-portaria-conjunta-n-01-2013-sas-svs-ms/file.

Oleribe OO, Oladipo OA, Ezieme IP, et al. From decentralization to commonization of HIV healthcare resources: keys to reduction in health disparity and equitable distribution of health services in Nigeria. Pan Afr Med J. 2016; 24. doi: 10.11604/pamj.2016.24.266.6286.

Colaço AD, Meirelles BHS, Heidemann ITSB, et al. O cuidado à pessoa que vive com HIV/AIDS na atenção primária à saúde. Texto Contexto Enferm. 2019, 28: 1-14. doi: 10.1590/1980-265X-TCE-2017-0339.

Published

2023-09-27

How to Cite

1.
PAULA-FRANÇA F Álisson, SANTANA RS. Can the absence of drug dispensing units in municipalities influence the abandonment of treatment by people living with HIV/AIDS?. Rev Bras Farm Hosp Serv Saude [Internet]. 2023Sep.27 [cited 2024May18];14(3):912. Available from: https://rbfhss.org.br/sbrafh/article/view/912

Issue

Section

ORIGINAL ARTICLES

Most read articles by the same author(s)